Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 EUR | +0.73% | +3.76% | -14.81% |
May. 06 | Encres Dubuit Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Encres Dubuit Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Strengths
- The stock, which is currently worth 2023 to 0.24 times its sales, is clearly overvalued in comparison with peers.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-14.81% | 9.03M | - | ||
+7.26% | 4B | D+ | ||
+20.12% | 1.89B | B+ | ||
+31.04% | 1.11B | - | ||
+4.75% | 1.01B | D+ | ||
+51.77% | 738M | - | - | |
+21.46% | 715M | - | ||
+51.00% | 690M | B- | ||
-3.74% | 671M | - | - | |
+24.69% | 546M | - | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- ALDUB Stock
- Ratings Encres DUBUIT